The move makes Oregon the 14th state to pass a law banning dextromethorphan sales to patients younger than 18 years old, joining states across the country in recognizing that limiting teen access to DXM is a proven way to prevent abuse, the Consumer Healthcare Products Association said.
The National Community Pharmacists Association shared with the Centers for Medicare and Medicaid Service a list of provisions it hopes will be included in the final rule for managed care organizations.
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz).
The National Association of Chain Drug Stores has submitted a statement to the House Ways and Means Committee highlighting pharmacy’s role in the healthcare system and urging passage of provider status legislation.
According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.